There are concerns in Alberta about the accessibility and affordability of Paxlovid, after the federal government ended its program supplying the COVID-19 treatment to provinces, which provided the drug for free to specific groups of high-risk patients.
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.